Why Editas Medicine Stock Soared as Much as 42% Higher This Week

Shares of Editas Medicine (EDIT 4.67%) charged sharply higher this week, soaring as much as 41.6%, according to data from S&P Global Market Intelligence. By the time the market closed on Friday, the stock was still up 34.8%.The catalyst that vaulted the gene editing specialist higher was the company's quarterly report, which included a surprise announcement.Alignment with the FDAOn Wednesday, Editas Medicine released its fourth-quarter results, which were better than investors had hoped. The company generat ...